Indications
Treatment of nonunion of tibia of at least 9 month duration, secondary to trauma, in skeletally mature patients, in cases where previous treatment with autograft has failed or use of autograft is unfeasible.
Composition
- Active substance
- eptotermin alfa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Osigraft
- Active substance
- eptotermin alfa
- ATC code
- M05BC02
- Therapeutic area
- Tibial Fractures
- Marketing authorisation holder
- Olympus Biotech International Limited
- Status
- Withdrawn